MedTrace Logo

Prophylactic Pregabalin Treatment Following Spinal Cord Injury

NCT06066918 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-06-24

No results posted yet for this study

Summary

Patients arriving to rehabilitation up to 3 months following SCI will be given (study group) or not (control group) Lyrica (75X2). They will be followed for central pain development.

Conditions

  • Spinal Cord Injuries
  • Spinal Cord Diseases

Interventions

DRUG

Pregabalin 75mg

Pregabalin 75 mg twice a day

Sponsors & Collaborators

  • Loewenstein Hospital

    lead OTHER

Principal Investigators

  • Amiram Catz, Catz · Loewenstein Rehabilitation Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-13
Primary Completion
2026-02-05
Completion
2026-02-05

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06066918 on ClinicalTrials.gov